Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content


Brazil suspends use of AstraZeneca COVID-19 vaccine in pregnant women

1 minute read
A medical worker prepares a dose of Oxford/AstraZeneca's COVID-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman

RIO DE JANEIRO, May 11 (Reuters) - Brazil's health regulator Anvisa said on Tuesday that it had suspended the use of the AstraZeneca (AZN.L) COVID-19 vaccine in pregnant women after learning that a woman had died from a stroke in an incident seen as possibly related to the immunization.

The 35-year-old woman, who died on May 10, was 23 weeks pregnant, Anvisa said, adding that it had not been informed of any other adverse events involving pregnant women.

Reporting by Pedro Fonseca, Editing by Rosalba O'Brien

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters